# AZD9164 Single Ascending Dose Study in Healthy Male Subjects

> **NCT00847249** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 65 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD9164
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00847249
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** —
- **Final completion:** 2009-04
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2009-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847249, "AZD9164 Single Ascending Dose Study in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00847249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*